Trials are an immense undertaking involving tens of thousands of participants. They’re likely to start this summer — but don’t expect quick results. And what’s a successful result, anyway?
Category: Vaccines
Drugmakers Tout COVID-19 Vaccines To Refurbish Their Public Image
Vaccines and antivirals have long been an afterthought but Johnson & Johnson and other firms are widely publicizing how they might stop COVID 19.
Chasing The Elusive Dream Of A COVID Cure
Thousands of researchers worldwide are looking for a treatment that will go beyond what remdesivir can do for COVID patients.
Anti-Vaccine Activists Latch Onto Coronavirus To Bolster Their Movement
Activists failed to convince state legislators that diseases like measles aren’t serious enough to require vaccination. Now they’re joining with conservatives and other anti-lockdown demonstrators who contend the coronavirus isn’t dangerous enough to justify staying home.
‘It’s Not Over Until It’s Over’: 5 Things To Know About Hitting The COVID-19 Peak
President Donald Trump says the country has seen a peak in new cases, but that doesn’t mean the end of the pandemic, experts say. Buckle in — we could be social distancing into 2022.
FAQs on Medicare Coverage and Costs Related to COVID-19 Testing and Treatment
These FAQs provide the latest guidance on testing and treatment related to COVID-19 for Medicare beneficiaries, including questions related to out-of-pocket costs, the COVID-19 vaccine, telehealth, extended supplies of medication, skilled nursing facil…
Maine Voters Consider U-Turn On Vaccine Exemptions
States tried to tighten vaccine requirements last year in the midst of measles outbreaks, but a backlash against a tougher law in Maine put a referendum on the ballot there. Voters weigh in on Super Tuesday.
As The Coronavirus Spreads, Americans Lose Ground Against Other Health Threats
Health care experts thought the battle was won against heart disease, measles, smoking, STDs and other life-threatening conditions and behaviors. Better think again.
Efforts To Move The Needle On Flu Shot Rates Get Stuck
In the past decade, federal and state governments have removed cost and access obstacles, but immunization rates remained flat. That worries public health officials.
Efforts To Move The Needle On Flu Shot Rates Get Stuck
In the past decade, federal and state governments have removed cost and access obstacles, but immunization rates remained flat. That worries public health officials.
